Amber Fradkin, Ph.D. Director, Particle Characterization Core Facility, KBI Biopharma at KBI Biopharma Linkedin Profile Associated Articles Innovative Single-Use Freeze and Thaw Platform for Bulk Drug Substance Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You in the Dark